These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 33210921)

  • 1. Mitochondria-Targeting Click-Derived Pyridinyltriazolylmethylquinoxaline-Based Y-Shaped Binuclear Luminescent Ruthenium(II) and Iridium(III) Complexes as Cancer Theranostic Agents.
    Roy N; Sen U; Madaan Y; Muthukumar V; Varddhan S; Sahoo SK; Panda D; Bose B; Paira P
    Inorg Chem; 2020 Dec; 59(23):17689-17711. PubMed ID: 33210921
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Half-Sandwich Iridium(III) and Ruthenium(II) Complexes Containing P^P-Chelating Ligands: A New Class of Potent Anticancer Agents with Unusual Redox Features.
    Li J; Tian M; Tian Z; Zhang S; Yan C; Shao C; Liu Z
    Inorg Chem; 2018 Feb; 57(4):1705-1716. PubMed ID: 29400963
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mitochondria specific highly cytoselective iridium(iii)-Cp* dipyridophenazine (dppz) complexes as cancer cell imaging agents.
    Roy N; Sen U; Ray Chaudhuri S; Muthukumar V; Moharana P; Paira P; Bose B; Gauthaman A; Moorthy A
    Dalton Trans; 2021 Feb; 50(6):2268-2283. PubMed ID: 33507192
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Highly potent half-sandwich iridium and ruthenium complexes as lysosome-targeted imaging and anticancer agents.
    Li J; Tian Z; Xu Z; Zhang S; Feng Y; Zhang L; Liu Z
    Dalton Trans; 2018 Nov; 47(44):15772-15782. PubMed ID: 30357192
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A mitochondria-targeting dinuclear Ir-Ru complex as a synergistic photoactivated chemotherapy and photodynamic therapy agent against cisplatin-resistant tumour cells.
    Zhang C; Guan R; Liao X; Ouyang C; Rees TW; Liu J; Chen Y; Ji L; Chao H
    Chem Commun (Camb); 2019 Oct; 55(83):12547-12550. PubMed ID: 31576841
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Biological Potential of Halfsandwich Ruthenium(II) and Iridium (III) Complexes.
    Ludwig G; Mojić M; Bulatović M; Mijatović S; Maksimović-Ivanić D; Steinborn D; Kaluđerović GN
    Anticancer Agents Med Chem; 2016; 16(11):1455-1460. PubMed ID: 26510901
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hetero-Bis-Conjugation of Bioactive Molecules to Half-Sandwich Ruthenium(II) and Iridium(III) Complexes Provides Synergic Effects in Cancer Cell Cytotoxicity.
    Biancalana L; Kostrhunova H; Batchelor LK; Hadiji M; Degano I; Pampaloni G; Zacchini S; Dyson PJ; Brabec V; Marchetti F
    Inorg Chem; 2021 Jul; 60(13):9529-9541. PubMed ID: 34156246
    [TBL] [Abstract][Full Text] [Related]  

  • 8. DNA targeting half sandwich Ru(II)-
    Mondal A; Sen U; Roy N; Muthukumar V; Sahoo SK; Bose B; Paira P
    Dalton Trans; 2021 Jan; 50(3):979-997. PubMed ID: 33355328
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Synthesis and evaluation of new salicylaldehyde-2-picolinylhydrazone Schiff base compounds of Ru(II), Rh(III) and Ir(III) as in vitro antitumor, antibacterial and fluorescence imaging agents.
    Palepu NR; Nongbri SL; Premkumar JR; Verma AK; Bhattacharjee K; Joshi SR; Forbes S; Mozharivskyj Y; Thounaojam R; Aguan K; Kollipara MR
    J Biol Inorg Chem; 2015 Jun; 20(4):619-38. PubMed ID: 25712889
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Anticancer effect evaluation in vitro and in vivo of iridium(III) polypyridyl complexes targeting DNA and mitochondria.
    Zhang H; Tian L; Xiao R; Zhou Y; Zhang Y; Hao J; Liu Y; Wang J
    Bioorg Chem; 2021 Oct; 115():105290. PubMed ID: 34426145
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Potential anticancer agent for selective damage to mitochondria or lysosomes: Naphthalimide-modified fluorescent biomarker half-sandwich iridium (III) and ruthenium (II) complexes.
    Ma W; Zhang S; Tian Z; Xu Z; Zhang Y; Xia X; Chen X; Liu Z
    Eur J Med Chem; 2019 Nov; 181():111599. PubMed ID: 31408807
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Luminescent anticancer ruthenium(ii)-p-cymene complexes of extended imidazophenanthroline ligands: synthesis, structure, reactivity, biomolecular interactions and live cell imaging.
    Sarkar B; Mondal A; Madaan Y; Roy N; Moorthy A; Kuo YC; Paira P
    Dalton Trans; 2019 Aug; 48(32):12257-12271. PubMed ID: 31339136
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Novel C,N-Cyclometalated Benzimidazole Ruthenium(II) and Iridium(III) Complexes as Antitumor and Antiangiogenic Agents: A Structure-Activity Relationship Study.
    Yellol J; Pérez SA; Buceta A; Yellol G; Donaire A; Szumlas P; Bednarski PJ; Makhloufi G; Janiak C; Espinosa A; Ruiz J
    J Med Chem; 2015 Sep; 58(18):7310-27. PubMed ID: 26313136
    [TBL] [Abstract][Full Text] [Related]  

  • 14. 2-Aryl-1
    Kar B; Shanavas S; Karmakar A; Nagendra AH; Vardhan S; Sahoo SK; Bose B; Kundu S; Paira P
    J Med Chem; 2024 Jul; 67(13):10928-10945. PubMed ID: 38812379
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Half-Sandwich Iridium and Ruthenium Complexes: Effective Tracking in Cells and Anticancer Studies.
    Li J; Guo L; Tian Z; Zhang S; Xu Z; Han Y; Li R; Li Y; Liu Z
    Inorg Chem; 2018 Nov; 57(21):13552-13563. PubMed ID: 30289251
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Similarities and differences in d
    Gilewska A; Barszcz B; Masternak J; Kazimierczuk K; Sitkowski J; Wietrzyk J; Turlej E
    J Biol Inorg Chem; 2019 Jun; 24(4):591-606. PubMed ID: 31115765
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Luminescent anticancer Ru(II)-arenebipyridine and phenanthroline complexes: Synthesis, characterization, DFT studies, biological interactions and cellular imaging application.
    P K A; Paira P
    J Inorg Biochem; 2020 Jul; 208():111099. PubMed ID: 32460056
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antitumor Effects of Ir(III)-2
    Panchangam RL; Rao RN; Balamurali MM; Hingamire TB; Shanmugam D; Manickam V; Chanda K
    Inorg Chem; 2021 Dec; 60(23):17593-17607. PubMed ID: 34767343
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Synthesis, characterization and anticancer activity in vitro and in vivo evaluation of an iridium (III) polypyridyl complex.
    Yi QY; Wan D; Tang B; Wang YJ; Zhang WY; Du F; He M; Liu YJ
    Eur J Med Chem; 2018 Feb; 145():338-349. PubMed ID: 29331805
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Studies of anticancer activity in vitro and in vivo of iridium(III) polypyridyl complexes-loaded liposomes as drug delivery system.
    Zhang WY; Du F; He M; Bai L; Gu YY; Yang LL; Liu YJ
    Eur J Med Chem; 2019 Sep; 178():390-400. PubMed ID: 31202127
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.